Syndax Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Syndax Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Syndax Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Syndax Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.0M | 93k | 21.61 |
| 2023-09-30 | $1.1M | 77k | 14.52 |
| 2023-06-30 | $1.1M | 54k | 21.12 |
| 2023-03-31 | $1.1M | 54k | 21.12 |
| 2022-12-31 | $1.5M | 58k | 25.45 |
| 2022-09-30 | $1.0M | 43k | 24.03 |
| 2022-06-30 | $890k | 46k | 19.24 |
| 2022-03-31 | $676k | 39k | 17.38 |
| 2021-12-31 | $851k | 39k | 21.89 |
| 2021-09-30 | $743k | 39k | 19.11 |
| 2021-06-30 | $733k | 43k | 17.17 |
| 2021-03-31 | $858k | 38k | 22.36 |
| 2020-12-31 | $583k | 26k | 22.24 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas